Ongoing Trials Studying Immunotherapy as a First-Line Treatment in Head and Neck Cancer

Barbara Ann Burtness, MD, professor of medicine, Clinical Research Program Leader, Head and Neck Cancers Program and Co-Director, Developmental Therapeutics Research Program at Yale Cancer Center, discusses the ongoing trials looking at immunotherapy as a first-line treatment in head and neck cancer.

Related Videos
Related Content